In Vitro Diagnostics/IVD Market Will Reach USD 87.21 Billion By 2023: Meticulous Research®

In Vitro Diagnostics/IVD Market By Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal, Thyroid), PCR], Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) – Global Forecast To 2024

London, United Kingdom - January 3, 2019 /MarketersMedia/ —

A report into the projected growth of the current IVD market by Meticulous Research® has produced lucrative forecasts for the industry. By 2024, the global IVD market is expected to reach $87.21 billion, growing at a CAGR of 5.7% from 2018.

Browse 237 market data tables and 42 figures spread through 301 pages and in-depth TOC on “IVD Market by Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal, Thyroid), PCR], Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC)- Global Forecast to 2024”

Download free sample report @ https://www.meticulousresearch.com/download-sample-report/?cp_id=4858

The researchers believe that the growth will be driven by a variety of factors. These include: rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing.

The report states that the reagents & kits currently accounts for the largest share of the total market and is expected to grow at a CAGR of 6% from 2018 to 2024. Meticulous Research® speculated as to why this area is emerging as the largest and fast-growing segment: “Due to repeat purchase, incessant product launches, number of on-going research activities, and growing prevalence of various acute as well as chronic infectious diseases.”

Immunoassay technique is a bioanalytical method in which the quantitation of the analyte depends on the reaction of an antigen and antibody. Applications of immunoassay include testing for cancer markers, diagnosing infectious diseases, cardiac analysis, therapeutic drug monitoring, and allergen tests. Immunoassay segment commanded the largest share of the global IVD market- owing to their greater adoption attributed to advantages such as inherent specificity, high throughput, high sensitivity, and low cost of the related instruments and reagents. Further, the growth in this market will be driven by technological advancements and rising demand for immunoassay-based tests attributed to aging population.

Based on applications, infectious diseases segment commanded the largest share of the global IVD market. The high share of this segment is attributed to large volume of IVD tests performed for infectious diseases, high incidence of various infectious diseases, and incessant technological advancements in the tests used for the detection of such diseases. Oncology is the fastest growing segment attributed to rising aging population, growing number of cases & deaths associated with cancer, growing field of personalized medicine in oncology, and technological advancements in oncology IVD products.

Based on end users, hospital laboratories were the largest end users of IVD products mainly due to high volume of diagnostic tests being performed in the hospitals.

The report states that North America is currently the home of most of the IVD companies. However, Asia-Pacific is named as the conducive area expected to grow most by 2024. Reasons cited for this include accelerated growth of the economies; improving healthcare infrastructure; growing accessibility to healthcare services & advanced products; increasing incidence of infectious and non-communicable diseases with aging population; growing income levels of middle-class population; and increasing number of hospitals and clinics.

The key players operating in the global IVD market are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthcare, Thermo Fisher Scientific Inc., Sysmex Corporation, bioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Qiagen N.V., and Agilent Technologies, Inc. among others.

Browse In-depth Company profiles and Report @ https://www.meticulousresearch.com/product/ivd-market

Scope of the Report:

Market by Product
Reagents & Kits
Instruments
Software & Services

Market by Technique
Immunoassay
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassays
Fluorescence Immunoassays
Colorimetric Immunoassays
Radioimmunoassay
Rapid Tests
Western Blotting
Enzyme-Linked Immunospot Assays
Clinical Chemistry
Metabolic Panel
Electrolyte Panel
Liver Panel
Lipid Profile
Renal Profile
Thyroid Function Panel
Molecular Diagnostics
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
Microarray
Hybridization
DNA Sequencing & Next-Generation Sequencing
Microbiology
Hematology
Coagulation and Hemostasis
Urinalysis
Other IVD Technologies

Market by Application
Infectious Diseases
Diabetes
Cancer/Oncology
Endocrinology
Cardiology
Nephrology
Others

Market by End User
Hospitals Laboratories
Independent Reference Laboratories
Point-Of-Care Testing
Patient Self-Testing
Academic and Research Institutes

Market by Geography
North America
U.S.
Canada
Europe
Germany
Italy
France
U.K.
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Australia
South Korea
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa.

Download free sample report @ https://www.meticulousresearch.com/download-sample-report/?cp_id=4858

Contact Info:
Name: Viren Shrivastava
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Wembley, Middlesex- HA0 4JH, U.K.
Phone: +44-203-868-8738
Website: https://www.meticulousresearch.com/product/ivd-market/

Source URL: https://marketersmedia.com/in-vitro-diagnosticsivd-market-will-reach-usd-8721-billion-by-2023-meticulous-research/465468

Source: MarketersMedia

Release ID: 465468